Danaparoid (Orgaran)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 17:43, 3 February 2019 by Warner-admin (talk | contribs) (Text replacement - "Category:Discontinued" to "Category:Discontinued drugs")
Jump to navigation Jump to search

General information

Class/mechanism: Low molecular weight heparin

History of changes in FDA indication

  • 6/26/2001: Initial FDA approval

Also known as

  • Brand name: Orgaran